您好，欢迎来到试剂信息网！ [登录] [免费注册]
试剂信息网
发布求购
位置：首页 > 产品库 > Fenoldopam mesylate
立即咨询
咨询类型：
     
*姓名：
*电话：
*单位：
Email：
*留言内容：
请详细说明您的需求。
*验证码：
 
Fenoldopam mesylate
本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
Fenoldopam mesylate图片
CAS NO:67227-57-0
包装与价格：
包装价格(元)
10 mM * 1 mL in DMSO电议
10mg电议
50mg电议
100mg电议
200mg电议
500mg电议

产品名称
非诺多泮甲磺酸盐
Fenoldopam methanesulfonate
SKF-82526 mesylate
产品介绍
Fenoldopam mesylate (SKF-82526) 是一种D1receptor激动剂和新型的lysine-specific demethylase 1(LSD1) 抑制剂 (IC50=0.8974 μM)。Fenoldopam mesylate 具有抗高血压和抗癌细胞增殖的活性，并能诱导细胞凋亡。
生物活性

Fenoldopam mesylate (SKF-82526) is aD1receptoragonist and a novellysine-specific demethylase 1(LSD1) inhibitor (IC50=0.8974 μM). Fenoldopam mesylate shows anti-hypertensive effects, anti-cancer cell proliferation activity and can induce cellsapoptosis[1][2][3].

IC50& Target

IC50: 0.8974 μM (LSD1)[2]

体外研究
(In Vitro)

Fenoldopam is a partial agonist with low efficacy at DA1 receptors linked to cAMP generation in the LLC-PK1 cells[1].
Fenoldopam (0-300 μM; 48 or 72 h) displays significant antiproliferative activity against RCC cell lines[2].
Fenoldopam (5 μM and 10 μM; 72 h) induces cell apoptosis in a dose-dependent manner[2].

Cell Proliferation Assay[1]

Cell Line:786-O, ACHN, and HK-2 cells
Concentration:0-300 μM
Incubation Time:48 or 72 hours
Result:Inhibited the growth of ACHN cells (IC50=16.55 μM, 48 h; IC50=10.34 μM, 72 h), 786-O cells (IC50=57.89 μM, 48 h; IC50=47.52 μM, 72 h), and HK2 cells (IC50>300 μM, 48h and 72 h).

Apoptosis Analysis[1]

Cell Line:ACHN cells
Concentration:5 μM and 10 μM
Incubation Time:72 hours
Result:Increased apoptotic cells from at 2.2% (control) to 47.7% (5 μM, fenoldopam) and 60.8% (10 μM, fenoldopam), respectively.
体内研究
(In Vivo)

Fenoldopam mesylate (subcutaneous injection; 100 mg/kg; once daily; 2 d) can induce arteritis in rats detected by magnetic resonance imaging (MRI)[3].

Animal Model:Female Sprague-Dawley rats[3]
Dosage:100 mg/kg
Administration:Subcutaneous injection; 100 mg/kg; once daily; 2 days
Result:Showed low-intensity areas and a high signal intensity region around the artery, and these findings were considered to be erythrocytes infiltrating the arterial wall and perivascular edema, respectively.
Observed perivascular edema histopathologically.
Clinical Trial
分子量

401.86

性状

Solid

Formula

C17H20ClNO6S

CAS 号

67227-57-0

中文名称

非诺多泮甲磺酸盐

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
In Vitro: 

DMSO : ≥ 36 mg/mL(89.58 mM)

H2O : 10 mg/mL(24.88 mM;Need ultrasonic)

*"≥" means soluble, but saturation unknown.

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM2.4884 mL12.4421 mL24.8843 mL
5 mM0.4977 mL2.4884 mL4.9769 mL
10 mM0.2488 mL1.2442 mL2.4884 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture)。-80℃ 储存时，请在 6 个月内使用，-20℃ 储存时，请在 1 个月内使用。